As a pleiotropic cytokine, the involvement of IL-33 in autoimmune diseases such as in rheumatoid arthritis (RA), inflammatory bowel diseases (IBD), and systemic lupus erythematosus (SLE) has been described [9]. This evidence concerns the gene IL33 and systemic lupus erythematosus.